Global Amphotericin B Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 0.22 Billion |
 Market Size (Forecast Year) |
USD 0.30 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球两性霉素 B 市场，按产品类型（静态滴剂、雾化吸入、局部病变注射、其他）、应用（阴道炎、念珠菌感染、利什曼病、黑热病、隐球菌感染、曲霉菌感染、其他）、给药途径（静脉、肠外、口服、其他）、药物类别（抗真菌药、全身性、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房）– 行业趋势和预测到 2030 年。
两性霉素 B 市场分析和规模
真菌感染患病率上升、新兴市场、医疗支出增加、政府资金和宣传举措不断增加，这些因素将扩大全球两性霉素 B 市场。不断增加的研发活动和临床试验将为 2023-2030 年预测期内的全球两性霉素 B 市场提供有利机会。抗真菌药物耐药性人口的增加以及两性霉素 B 的副作用（如嘴唇发青、癫痫、腹痛、麻木、发烧和其他常见影响）是阻碍市场增长的因素，并将在预测期内进一步挑战全球两性霉素 B 市场。
Data Bridge Market Research 分析，2022 年全球两性霉素 b 市场规模为 2.2 亿美元，到 2030 年将飙升至 3 亿美元，预计在 2023 年至 2030 年的预测期内，复合年增长率将达到 4.6%。这表明了市场价值。由于真菌疾病数量的增加，“静态下降”在全球两性霉素 b 市场的产品领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
两性霉素 B 市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史年份 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按产品类型（静态滴剂、雾化吸入、局部病变注射、其他）、应用（阴道炎、念珠菌感染、利什曼病、黑热病、隐球菌感染、曲霉菌感染、其他）、给药途径（静脉、肠外、口服、其他）、药品类别（抗真菌药、全身性、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房） |
|
覆盖国家 |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America |
|
Market Players Covered |
Bristol-Myers Squibb Company (US), MATINAS BIOPHARMA HOLDINGS, INC. (US), Nano-X Imaging LTD. (Israel), Nanomerics (UK), DNDi (Geneva), Abzena Ltd (UK), Bharat Serums and Vaccines Limited (BSV) (India), Astellas Pharma Inc.(Japan), Leadiant Biosciences (Italy), Inc., Lilly (US), InterMune (US), Jina Pharmaceuticals (US), SteriMax (India), and XGen Pharmaceuticals DJB, Inc. (US) among other |
|
Market Opportunities |
|
Market Definition
Amphotericin B is a polyene antifungal antibiotic which is produced by Streptomyces nodosus. It is used for the treatment of fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. It acts by stopping the growth of fungi as it binds to ergosterol (an important component of fungal membrane). It further causes depolarization of the membrane and altering cell membrane permeability which leads to leakage of important intracellular components, cell rupture, and results in cell death. It is given by injection into a vein.
Amphotericin B Market Dynamics
Drivers
- Increase in cases of hospital acquired infection
Hospital-acquired infections (HAIs) can indeed contribute to an increase in the demand for medications such as Amphotericin B, which is an antifungal medication. HAIs are infections that patients acquire during their stay in a healthcare facility, including hospitals, clinics, and long-term care facilities. These infections can be caused by bacteria, viruses, fungi, or other pathogens, and they pose a significant challenge to patient care and overall healthcare systems.
- Increase in demand for effective antifungal drugs
Fungal infections have been on the rise globally, affecting various populations, including immunocompromised individuals, patients with chronic diseases, and those undergoing invasive medical procedures. Factors such as the aging population, increased use of immunosuppressive therapies, and the spread of drug-resistant fungal strains contribute to the growing incidence of fungal infections.
Opportunities
Growing unhygienic practices
Unhygienic practices and the presence of hospital-acquired infections are significant concerns for patient safety and public health. These practices can lead to increased rates of infections and pose serious risks to patients.
Restraints/Challenges
High investment requirements
However, obstacles such as high investment requirements, high treatment costs, and expensive capital expenditure on equipment are expected to stymie market expansion, as are technical challenges with sample collection and a lack of suitable reimbursement.
This global amphotericin b market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on the surgical microscopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In 2021, SP Accure Labs announced launching of amphotericin B emulsion. This drug is used in treatment of mucormycosis
- In 2021, Celon Laboratories announced launching of amphotericin B emulsion. This drug can be used in treatment of mucormycosis commonly known as black fungus
- In 2021, TLC a drug maker company announced the launch of liposomal amphotericin B in India. The product is named AmphoTLC and can be effective in the treatment of mucormycosis
Global Amphotericin B Market Scope
The global amphotericin b market is segmented on the basis of product type, application, route of administration, drug class, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- STATIC DROPS,
- ATOMIZATION INHALATION,
- LOCAL LESION INJECTION,
- OTHER
Application
- VAGINITIS
- CANDIDA INFECTION
- LEISHMANIASIS
- KALA-AZAR
- CRYPTOCOCCAL INFECTION
- ASPERGILLUS INFECTION
- OTHER
Route Of Administration
- INTRAVENOUS
- PARENTERAL
- ORAL
- OTHERS
Drug Class
- ANTIFUNGALS
- SYSTEMIC
- OTHER
End User
- CLINIC
- HOSPITAL
- OTHERS
Distribution Channel
- HOSPITAL PHARMACY
- RETAIL PHARMACY
- ONLINE PHARMACY
Global Amphotericin B Market Regional Analysis/Insights
The global amphotericin b market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, drug class, end-users, and distribution channel as referenced above.
The countries covered in the global amphotericin b market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
北美在全球两性霉素 B 市场占据主导地位，因为该地区医疗保健计划不断增加、主要市场参与者的强大影响力、慢性真菌病病例不断增加以及研究活动不断增加。
预计亚太地区将在 2023 年至 2030 年的预测期内实现显着增长，这得益于政府加强宣传力度、该地区研究活动不断增多、拥有大量未开发市场、人口众多以及对优质医疗服务的需求不断增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
医疗保健基础设施增长安装基础和新技术渗透
全球两性霉素 b 市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、全球稀有生物标志物市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对手术显微镜市场的影响。数据适用于 2010-2020 年的历史时期。
竞争格局和全球两性霉素 B 市场份额分析
全球两性霉素 b 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
全球两性霉素 B 市场的一些主要参与者包括：
- 百时美施贵宝公司 (美国)
- MATINAS BIOPHARMA HOLDINGS, INC.（美国）
- Nano-X Imaging LTD.（以色列）
- Nanomerics（英国）
- DNDi（日内瓦）
- Abzena Ltd（英国）
- 印度血清和疫苗有限公司 (BSV) (印度)
- 安斯泰来制药株式会社（日本）
- Leadiant Biosciences（意大利）有限公司
- 礼来（美国）、InterMune（美国）
- Jina Pharmaceuticals（美国）
- SteriMax（印度）
- XGen Pharmaceuticals DJB, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
